Lv5
1240 积分 2023-08-07 加入
Identification of a Novel 2,8-Diazaspiro[4.5]decan-1-one Derivative as a Potent and Selective Dual TYK2/JAK1 Inhibitor for the Treatment of Inflammatory Bowel Disease
1个月前
已完结
Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with In Vivo Activity
1个月前
已完结
Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?
1个月前
已完结
Remibrutinib, a Novel Bruton Tyrosine Kinase Inhibitor, Exhibits Improved Target Selectivity and Potency in Vitro
2个月前
已完结
Harmonized analysis of PBMC by mass cytometry
2个月前
已完结
Peripheral blood mononuclear cell- transcriptome signatures of atopic dermatitis and prediction for the efficacy of dupilumab
2个月前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
2个月前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
2个月前
已完结
Recent progress in degradation of membrane proteins by PROTACs and alternative targeted protein degradation techniques
2个月前
已完结
The role of protein kinase C isoenzymes in the pathogenesis of human autoimmune diseases
2个月前
已完结
The fountain of youth of mitochondrial research
皖公网安备34019202002308
